Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.

myTempleHealth
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

These Conditions Increase Your Risk of Serious COVID-19 Complications

View All Blog Posts

Know Your Risks and What Treatments May Be Available if Diagnosed With COVID

Posted by Temple Health

In the early days of the pandemic, very little was known about the novel coronavirus since doctors had not encountered it before. Now that medical researchers have had time to study the impact of the virus on patients around the world, we are gaining a better understanding of how it behaves and affects different populations.

A growing body of research shows that having certain underlying health conditions raises the risk of becoming seriously ill or dying from COVID-19. According to one study, some conditions may double or even triple the risk of death for COVID-19 patients.

Understanding who is at an increased risk of serious complications helps doctors provide appropriate care. Read on for a list of conditions associated with COVID-19 complications and the treatments we offer at Temple for high-risk patients who are diagnosed with COVID-19.

Conditions that Raise the Risk of Severe Illness from COVID

According to the Centers for Disease Control and Prevention (CDC), you have a higher risk of severe illness or death due to COVID-19 if you have one of these conditions:

  • Cancer
  • Chronic kidney disease
  • Chronic obstructive pulmonary disease (COPD)
  • Heart conditions, including heart failure, coronary artery disease or cardiomyopathies
  • Weakened immune system due to organ transplant
  • Obesity
  • Pregnancy
  • Sickle cell disease
  • Smoking
  • Type 2 diabetes

As more data becomes available, the list above is likely to change. According to the CDC, you might also have a higher risk of severe illness or death due to COVID-19 if you have one of these conditions (but more research is needed to know for sure):

  • Moderate to severe asthma
  • Cerebrovascular disease
  • Cystic fibrosis
  • High blood pressure
  • Weakened immune system due to blood or bone marrow transplant, immune deficiencies, HIV, or use of corticosteroids or other medicines that weaken the immune system
  • Neurologic conditions, such as dementia
  • Liver disease
  • Overweight
  • Pulmonary fibrosis
  • Thalassemia
  • Type 1 diabetes

New Antibody Infusion Treatments Available for High-Risk Patients with COVID-19

Monoclonal Antibody Infusion Treatment for COVID video cover
Learn about monoclonal antibody infusion therapy — how it works, its potential benefits and more, offered through the Temple Lung Center.
Learn about monoclonal antibody infusion therapy — how it works, its potential benefits and more, offered through the Temple Lung Center.

If you’ve just been diagnosed with COVID-19 and have any of the conditions previously mentioned, an antibody infusion at the Temple Lung Center may help reduce your risk of developing severe disease. Through our COVID Monoclonal Antibody Infusion Clinic, we offer 2 kinds of antibody treatments that signal your immune system to attack the virus. Both therapies have been approved for FDA emergency use authorization (EUA) for patients who meet specific criteria.

To find out if you qualify for this treatment, request an appointment with one of our pulmonologists today or call 800-TEMPLE-MED (800-836-7536).

These monoclonal antibody therapies are also available with clinical trials using these agents in other patients with COVID who do not meet the criteria.

 

Copyright 2020-2021 © Baldwin Publishing, Inc. All rights reserved. Health eCooking® is a registered trademark of Baldwin Publishing, Inc. Cook eKitchen™ is a designated trademark of Baldwin Publishing, Inc. Any duplication or distribution of the information contained herein without the express approval of Baldwin Publishing, Inc. is strictly prohibited.

See More Posts In